Study of glue extrusion after endoscopic N-butyl-2-cyanoacrylate injection on gastric variceal bleeding

Table 1 Baseline characteristics of the patients

Variables at baseline	n (%)
Total number	148
Median age (yr)	50.13 ± 13.55, (14-78)
Sex ratio (M:F)	108:40
Underlying cause
Viral hepatitis B	87 (58.8)
Viral hepatitis C	7 (4.7)
Alcoholic cirrhosis	14 (9.4)
Primary biliary cirrhosis	6 (4.1)
Drug-induced liver cirrhosis	2 (1.3)
Budd-Chiari syndrome	3 (2.0)
CTPV	4 (2.7)
Wilson’s disease	1 (0.67)
Unknown etiology	24 (16.2)
Association with other diseases
Type-2 diabetes	16 (10.8)
Primary hepatic carcinoma	12 (8.1)
Hypertensive disease	9 (6.1)
Portal vein thrombogenesis	3 (2.0)
Clinical classification
Isolated GV	30 (20.3)
EGV received EVS or EVL	72 (48.6)
Residual GV after EVS or EVL	20 (13.5)
GV bleeding after disconnection	18 (12.2)
Other condition	8 (5.4)
Sarin’s category (%)
GOV-1	68 (45.9)
GOV-2	49 (33.1)
IGV-1	30 (20.3)
IGV-2	1 (0.67)
Child-Pugh class
A/B/C	42/73/33

GV: Gastric varices; EGV: Esophagogastric variceal; GOV: Gastroesophageal varices; IGV: Isolated gastric varices; CTPV: Cavernous transformation of the portal vein.